Related Experiment Video
Updated: Jun 27, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Unique pharmacology of KAR-2, a potential anti-cancer agent: absorption modelling and selective mitotic spindle
Isabel Gonzalez-Alvarez1, Marta Gonzalez-Alvarez, Davinia Oltra-Noguera
1Department Ingeniería, Area Farmacia y Tecnología Farmacéutica, Universidad Miguel Hernández, Ctra. Alicante-Valencia, Alicante, Spain.
Abstract:
Bis-indols are a large group of the anti-cancer agents, which effectively arrest the uncontrolled division of the cancerous cells. Their use in clinical chemotherapy is still limited because of: (i) the non-specific targeting of the mitotic cells; (ii) low bioavailability of the drugs. KAR-2 has been identified as a tubulin binding agent which displays significantly lower cytotoxicity but favourable anti-cancer potency than its mother molecule, vinblastine. The objective of this paper, on one hand, was to show that the human intestinal epithelial Caco-2 cells, used for pharmacokinetic studies display distinct sensitivity against KAR-2 and vinblastine due to their distinct targeting of mitotic and interphase microtubular systems. We showed that KAR-2 impeded specifically the cell division. On the other hand, we elucidated the transport mechanisms of KAR-2 as compared to vinblastine, applying pharmacokinetic modelling based upon the combination of the data obtained from in situ animal and in vitro cell level experiments. The Caco-2 cell line and in in situ intestinal perfusion experiments in rat small intestine showed that vinblastine and KAR-2 are substrates of secretion transporters but with different affinity and KAR-2 presents a higher passive diffusion permeability. The information obtained from the kinetic modelling of each type of experiments rendered it possible to apply a single mathematical model to the whole (in vitro and in situ) data set including the adequate scale-up parameters. The model was validated by means of a model selection procedure based on the goodness of fit indexes to the experimental data. This unified quantitative model which characterizes the absorption/efflux features of KAR-2 as compared to vinblastine revealed its more favourable intestinal permeability. In addition, our pharmacokinetic analyses evaluated in this study showed the advantages of the modelling approach in maximizing of the information obtained from experimental data.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Inhibition of Cdk Activity
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Mitogens and the Cell Cycle
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
